Related references
Note: Only part of the references are listed.Atherosclerosis and Nanomedicine Potential: Current Advances and Future Opportunities
Fan Jiang et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Translational Theragnosis of Ovarian Cancer: where do we stand?
Maria Grazia Perrone et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Novel Antiplatelet Agents in Cardiovascular Disease
Maximilian Tscharre et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2020)
Age-Dependent Disparities in the Prevalence of Single and Clustering Cardiovascular Risk Factors: A Cross-Sectional Cohort Study in Middle-Aged and Older Adults
Pawel Macek et al.
CLINICAL INTERVENTIONS IN AGING (2020)
Thrombo-Inflammation in Cardiovascular Disease: An Expert Consensus Document from the Third Maastricht Consensus Conference on Thrombosis
Elisa d'Alessandro et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Inhibition of cyclooxygenase-1 does not reduce mortality in post-ischemic stroke rats
Ira S. Rostevanov et al.
NEUROSCIENCE LETTERS (2020)
Eicosanoids, prostacyclin and cyclooxygenase in the cardiovascular system
Jane A. Mitchell et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Germinal Center-Derived Antibodies Promote Atherosclerosis Plaque Size and Stability
Monica Centa et al.
CIRCULATION (2019)
Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability
Maria Laura Pati et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Platelet activation markers in evaluation of thrombotic risk factors in various clinical settings
Meganathan Kannan et al.
BLOOD REVIEWS (2019)
Bioactive peptides and proteins as alternative antiplatelet drugs
Kannan R. R. Rengasamy et al.
MEDICINAL RESEARCH REVIEWS (2019)
Targeting COX-1 by mofezolac-based fluorescent probes for ovarian cancer detection
Antonio Scilimati et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Intelligent Microarray Data Analysis through Non-negative Matrix Factorization to Study Human Multiple Myeloma Cell Lines
Gabriella Casalino et al.
APPLIED SCIENCES-BASEL (2019)
Synthesis and antitumor evaluation of hybrids of 5,8-dioxo-5,8-dihydroisoquinoline4-carboxylates and carbohydrates
Wanderson A. da Silva et al.
FUTURE MEDICINAL CHEMISTRY (2018)
Platelet collagen receptor Glycoprotein VI-dimer recognizes fibrinogen and fibrin through their D-domains, contributing to platelet adhesion and activation during thrombus formation
I. Induruwa et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Fourth Universal Definition of Myocardial Infarction (2018)
Kristian Thygesen et al.
GLOBAL HEART (2018)
Synthesis and mechanistic evaluation of novel N′-benzylidene-carbohydrazide-1H-pyrazolo[3,4-b]pyridine derivatives as non-anionic antiplatelet agents
Andre L. Lourenco et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Structural basis for selective inhibition of Cyclooxygenase-1 (COX-1) by diarylisoxazoles mofezolac and 3-(5-chlorofuran-2-yl)-5-methy1-4-phenylisoxazole (P6)
Gino Cingolani et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Effect of mofezolac-galactose distance in conjugates targeting cyclooxygenase (COX)-1 and CNS GLUT-1 carrier
Maria Grazia Perrone et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
The genetic basis of antiplatelet and anticoagulant therapy: A pharmacogenetic review of newer antiplatelets (clopidogrel, prasugrel and ticagrelor) and anticoagulants (dabigatran, rivaroxaban, apixaban and edoxaban)
Cormac T. O'connor et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)
The risk of bleeding with the use of antiplatelet agents for the treatment of cardiovascular disease
Ashwin S. Nathan et al.
EXPERT OPINION ON DRUG SAFETY (2017)
Differential inhibitory action of apixaban on platelet and fibrin components of forming thrombi: Studies with circulating blood and in a platelet-based model of thrombin generation
Lluis Pujadas-Mestres et al.
PLOS ONE (2017)
Flavonolignans inhibit the arachidonic acid pathway in blood platelets
Michal Bijak et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2017)
Isoxazole-Based-Scaffold Inhibitors Targeting Cyclooxygenases (COXs)
Maria Grazia Perrone et al.
CHEMMEDCHEM (2016)
COX-1 Inhibitors: Beyond Structure Toward Therapy
Paola Vitale et al.
MEDICINAL RESEARCH REVIEWS (2016)
Selective Cyclooxygenase-1 Inhibition by P6 and Gastrotoxicity: Preliminary Investigation
Maria Grazia Perrone et al.
PHARMACOLOGY (2015)
PET radiotracer [18F]-P6 selectively targeting COX-1 as a novel biomarker in ovarian cancer: Preliminary investigation
Maria Grazia Perrone et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Selective COX-1 inhibition as a target of theranostic novel diarylisoxazoles
Paola Vitale et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
In vitro and in vivo analysis of the antithrombotic and toxicological profile of new antiplatelets N-acylhydrazone derivatives and development of nanosystems Determination of novel NAH derivatives antiplatelet and nanotechnological approach
Plinio Cunha Sathler et al.
THROMBOSIS RESEARCH (2014)
Synthesis, Pharmacological Characterization, and Docking Analysis of a Novel Family of Diarylisoxazoles as Highly Selective Cyclooxygenase-1 (COX-1) Inhibitors
Paola Vitale et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Human Cytomegalovirus Inhibitor AL18 Also Possesses Activity against Influenza A and B Viruses
Giulia Muratore et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Synthesis and evaluation of anti-thrombotic activity of benzocoumarin amide derivatives
Koneni V. Sashidhara et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Poly(2-ethyl-2-oxazoline) as Alternative for the Stealth Polymer Poly(ethylene glycol): Comparison of in vitro Cytotoxicity and Hemocompatibility
Marius Bauer et al.
MACROMOLECULAR BIOSCIENCE (2012)
The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-life
Jane L. Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Selective COX-1 Inhibition: A Therapeutic Target to be Reconsidered
M. G. Perrone et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1
Gilad Rimon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
In silico pK(a) Prediction and ADME Profiling
Gabriele Cruciani et al.
CHEMISTRY & BIODIVERSITY (2009)
A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for ligands and proteins (FLAP): Theory and application
Massimo Baroni et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2007)
Hydrogen bonding interactions of covalently bonded fluorine atoms: From crystallographic data to a new angular function in the GRID force field
E Carosati et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis.
D Fischer et al.
BIOMATERIALS (2003)
The productive conformation of arachidonic acid bound to prostaglandin synthase
MG Malkowski et al.
SCIENCE (2000)
Share Paper
